The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Knudson, R. J., Lebowitz, M. D., Holberg, C. J., & Burrows, B. A. (1983) · PubMed · doi:10.1164/arrd.1983.127.6.725 · Cited by 1,907
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Self-citationThe changing epidemiology of cystic fibrosis
FitzSimmons, S. C. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83478-x · Cited by 928
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz, R. M., Schidlow, D. V., Wilmott, R. W., Astley, S. J., McBurnie, M. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282403 · Cited by 458
Self-citationPathogenesis of cystic fibrosis
Koch, C., & Høiby, N. (1993) · The Lancet · doi:10.1016/0140-6736(93)92422-p · Cited by 426
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., Ramsey, B. W., & Clausen, C. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514631 · Cited by 421
Self-citationCLONIDINE IN BENZODIAZEPINE WITHDRAWAL
KESHAVAN, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92810-7 · Cited by 302
Quantitative Deposition of Aerosolized Gentamicin in Cystic Fibrosis
Ilowite, J. S., Gorvoy, J. D., & Smaldone, G. C. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.6.1445 · Cited by 247
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
Mendelman, P. M., Smith, A. L., Lévy, J., Weber, A., Ramsey, B. W., & Davis, R. L. (1985) · PubMed · doi:10.1164/arrd.1985.132.4.761 · Cited by 216
Self-citationMacLusky, I., Gold, R., Corey, M. L., & Levison, H. (1989) · Pediatric Pulmonology · doi:10.1002/ppul.1950070110 · Cited by 148
Cited by
Pseudomonas Aeruginosa Biofilms in Cystic fibrosis
H⊘iby, N., Ciofu, O., & Bjarnsholt, T. (2010) · Future Microbiology · doi:10.2217/fmb.10.125 · Cited by 666
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
Langton Hewer, S. C., & Smyth, A. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004197.pub4 · Cited by 324
Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms
ALKAWASH, M. A., SOOTHILL, J. S., & SCHILLER, N. L. (2006) · APMIS · doi:10.1111/j.1600-0463.2006.apm_356.x · Cited by 276
Pneumonia Due to Pseudomonas aeruginosa
Fujitani, S., Sun, H.-Y., Yu, V. L., & Weingarten, J. A. (2011) · Chest · doi:10.1378/chest.10-0166 · Cited by 273
Metadata
- Authors
- Geller, D. E., Pitlick, W. H., Nardella, P. A., Tracewell, W. G., & Ramsey, B. W.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 122
- Issue
- 1
- Pages
- 219-226
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2105443867
- Cited by
- 300
- References
- 29
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis. https://app.cochat.ai/papers/10.1378/chest.122.1.219
- The paper
- Geller, D. E., Pitlick, W. H., Nardella, P. A., Tracewell, W. G., & Ramsey, B. W. (2002). Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis. Chest. https://doi.org/10.1378/chest.122.1.219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.